Alpha Stem Cell Clinic for Northern and Central California

The UC Davis Alpha Stem Cell Clinic (ASCC) has successfully implemented procedures for improved operations and streamlined processes for conducting cell and gene therapy clinical trials. The ASCC has played a leading role in the increased number of cell and gene therapy protocols enrolled in at UC Davis Health by providing the infrastructure needed for these complicated trials. The ASCC grant funding provided the ability to expand the successful operation and provided support for even more centralized activities. It also provided the financial support critical to programs that enhance patient recruitment and adherence to protocol requirements; improvement in time/efficiency of the administration of trial therapeutics; initiation of training for new support staff and the provision of regulatory support. UC Davis Health (UCDH) and ASCC serve patients throughout Northern and Central California. Our catchment area represents approximately 6 million people with many lacking access to cell and gene therapies. Our physicians are committed to ensuring these patients are referred to only legitimate sites, avoiding dangerous unregulated clinics where non-FDA approved stem cell applications can cause more harm than good. The UC Davis ASCC along with the Alpha Clinic Network sites continue to work collectively to ensure that stem cell and gene therapy clinical trial resources and access are available to a diverse patient population throughout the state of California. The ASCC provides an excellent value proposition for both patients and trial sponsors, by leveraging the success of the UC Davis Stem Cell Program and Gene Therapy Center through the number of cell-based clinical trials brought to UCDH with the connections established. Patients receive exceptional care and support from highly trained ASCC staff members with a long history of working together coordinating clinical projects involving cooperation between different departments. Clinical trial sponsors benefit from rigorously designed and efficiently run clinical trials with a diverse patient population to draw from, as well as opportunities for continued collaboration. The ASCC has fostered strong relationships with statewide and national medical program networks, has a commitment to enhance access to stem cell and gene therapy clinical trials, is dedicated to developing novel therapies for patients with rare diseases and works alongside the NIH-funded consortium of CTSC/CTSA academic research institutions. Through these resources the UC Davis ASCC has the ability to increase the overall value of the Alpha Clinic Network. These resources also serve to expand our extensive portfolio of ongoing and planned clinical trials, creating more opportunities to develop stem cell and regenerative medicine cures for Californians.